Get the week's hottest news stories, our most popular reviews, and fantastic competitions straight to your inbox with our free weekly newsletter.
Learn more
Showing posts with label Could. Show all posts
Showing posts with label Could. Show all posts
Wednesday, November 20, 2013
Samsung said to be prepping 560ppi display, Galaxy S5 could be first up
Galaxy S5 might pack in more pixels per inch than the Galaxy S4
Next year's smartphones from Samsung could offer higher resolutions and more pixels per inch than the already-stellar-looking displays the company came out with this year.
Samsung's preparing to make AMOLED displays with 560ppi for screens as small as five inches, according to German electronic site OLED.at citing Samsung Display CEO Kinam Kim.
That means the South Korean electronics giant would have resolutions topping out at an even clearer 2560 x 1440 in 2014.
While no specific phones were attached to this report, it could be a killer feature for Samsung's unveiling of the next-generation Galaxy S5 smartphone rumored for early next year.
If Samsung's future phones boast 560ppi and 2560 x 1440 resolution, it'll most certainly be a marketing cornerstone.
Pixels per inch measures the number of pixels contained in one square inch of a display, so there would be 560 pixels in each square inch of Samsung's 2014 smartphones.
Compare that to the company's precious 5-inch flagship, the Samsung Galaxy S4. It featured a Super AMOLED too, but it was only 441ppi with a 1920 x 1080 resolution.
The iPhone 5S has an LCD with 326ppi and 640 x 1136 pixels.
If Samsung were to release a Galaxy S5 smartphone with 556ppi, it would have 230 more pixels per inch than Apple's current hardware.
Of course, the human eye may not be able to see the additional pixels packed into every inch, as anything beyond around 300ppi is lost without a microscope. But science is no match for marketing specs.
Samsung said to be prepping 560ppi display, Galaxy S5 could be first up
Galaxy S5 might pack in more pixels per inch than the Galaxy S4
Next year's smartphones from Samsung could offer higher resolutions and more pixels per inch than the already-stellar-looking displays the company came out with this year.
Samsung's preparing to make AMOLED displays with 560ppi for screens as small as five inches, according to German electronic site OLED.at citing Samsung Display CEO Kinam Kim.
That means the South Korean electronics giant would have resolutions topping out at an even clearer 2560 x 1440 in 2014.
While no specific phones were attached to this report, it could be a killer feature for Samsung's unveiling of the next-generation Galaxy S5 smartphone rumored for early next year.
If Samsung's future phones boast 560ppi and 2560 x 1440 resolution, it'll most certainly be a marketing cornerstone.
Pixels per inch measures the number of pixels contained in one square inch of a display, so there would be 560 pixels in each square inch of Samsung's 2014 smartphones.
Compare that to the company's precious 5-inch flagship, the Samsung Galaxy S4. It featured a Super AMOLED too, but it was only 441ppi with a 1920 x 1080 resolution.
The iPhone 5S has an LCD with 326ppi and 640 x 1136 pixels.
If Samsung were to release a Galaxy S5 smartphone with 556ppi, it would have 230 more pixels per inch than Apple's current hardware.
Of course, the human eye may not be able to see the additional pixels packed into every inch, as anything beyond around 300ppi is lost without a microscope. But science is no match for marketing specs.
Get the week's hottest news stories, our most popular reviews, and fantastic competitions straight to your inbox with our free weekly newsletter.
Learn moreSunday, October 6, 2013
Reducing drug costs for patients could improve outcomes for high blood pressure
Main Category: Hypertension
Also Included In: Health Insurance / Medical Insurance
Article Date: 01 Aug 2013 - 1:00 PDT Current ratings for:
Reducing drug costs for patients could improve outcomes for high blood pressure
Visit our hypertension section for the latest news on this subject.
6 Oct. 2013. APA
'Reducing drug costs for patients could improve outcomes for high blood pressure'
Also Included In: Health Insurance / Medical Insurance
Article Date: 01 Aug 2013 - 1:00 PDT Current ratings for:
Reducing drug costs for patients could improve outcomes for high blood pressure
Expanding health insurance coverage and reducing drug costs that are paid by patients (drug co-payments) in countries without universal free healthcare, such as the United States, may improve the treatment, and control of high blood pressure (hypertension, a condition which affects one billion people worldwide and leads to 7.5 million deaths), according to a study by UK and Canadian researchers published in this week's PLOS Medicine.
Will Maimaris from the London School of Hygiene & Tropical Medicine and colleagues from the Population Health Research Institute and McMaster University in Canada reviewed 53 published studies and found an association between reduced co-payments for health care, including for medications, and improved hypertension control and treatment adherence in multiple US studies, and in studies from Finland, Israel, and Brazil.
The authors also found that in US settings, health insurance coverage and having a routine physician or place of care were linked to improved hypertension outcomes.
However, in their review, the authors found that there were few studies in low-and middle-income countries, which bear most of the global burden of hypertension, and also that there is an urgent need for studies that evaluate how aspects of health care systems other than financing (such as delivery and governance mechanisms) and interactions between health care system arrangements affect hypertension outcomes. The authors argue that without the results of such studies, governments and national and international organizations will not know the best ways to deal effectively with the global public-health crisis posed by hypertension.
The authors say: "This review supports the minimization of medication co-payments in health insurance plans, and although studies were largely conducted in the US, the principle is likely to apply more generally."
They add: "Studies that identify and analyse complexities and links between health systems arrangements and their effects on hypertension management are required, particularly in low-and middle-income countries."
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.Visit our hypertension section for the latest news on this subject.
Funding: This research was part of the HOPE-4 project. This part of the HOPE-4 project was funded by the Canadian Institutes of Health Research with an award number IHR-120389. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Citation: Maimaris W, Paty J, Perel P, Legido-Quigley H, Balabanova D, et al. (2013) The Influence of Health Systems on Hypertension Awareness, Treatment, and Control: A Systematic Literature Review. PLoS Med 10(7): e1001490. doi:10.1371/journal.pmed.1001490
Public Library of Science
Please use one of the following formats to cite this article in your essay, paper or report:MLA
6 Oct. 2013.
Please note: If no author information is provided, the source is cited instead.
'Reducing drug costs for patients could improve outcomes for high blood pressure'
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Wednesday, September 25, 2013
How Ted Cruz's Anti-Obamacare Filibuster Could Cost Him Millions
WASHINGTON — Texas Sen. Ted Cruz’s quixotic campaign to defund Obamacare — currently culminating in an hours-long quasi-filibuster on the Senate floor — has caused conservative activists across the country to swoon.
But one key contingent of the Republican Party is decidedly unimpressed with the gambit: big-ticket donors.
According to several Republican sources, most of whom declined to disparage a rising star on the record, the party’s donor class is rolling its eyes at Cruz’s last-minute, long-shot attempt to keep the controversial health care law from fully going into effect — dismissing it as unintelligible parliamentary trickery at best, and counterproductive self-promotion at worst.
Cruz, who most Republicans believe is positioning himself for a 2016 presidential run, will need the support of at least a portion of the party’s moneyed donors to stay competitive in a primary. But skeptics say he’s running the risk of being seen as unserious by the same people he will need to write him checks in a couple of years.
“Sure, he’s revving up the base, but so did Michele Bachmann and Pat Buchanan,” said one longtime Republican strategist who has worked on multiple state and national campaigns. “If you’re serious about running for president… you need the serious money, more than the direct mail crowd and the small money donors.”
“That,” the Republican said, “is the difference between winning the Iowa Caucus and winning in a serious state like Florida.”
Like most Americans, Republican donors generally oppose Obamacare — but many disagree with the tactics Cruz has employed to block it. The Texas senator has pursued a strategy that could force a government shutdown unless funding for the law is revoked.
“People see it as an inside-the-beltway play, and I think donors see it the same way,” said one operative with ties to major GOP fundraisers. He noted that while activists may take visceral satisfaction in Cruz’s campaign, many donors are more results-oriented — and they’re savvy enough to know that none of his maneuvering will actually stop the law from being implemented.
But Cruz has never shown much interest in, or capacity for courting his party’s elite. He was elected in Texas by taking on the favored candidate of the establishment and running to his right as a champion of the common conservative voter. And at a Republican National Committee fundraiser this week in Manhattan, Cruz was one of the only prospective 2016 candidates who didn’t show his face.
As of June 30, Cruz’s PAC, the Jobs, Growth & Freedom Fund, raised just $313,323 with $183,537 cash on hand, according to OpenSecrets.org. That’s a far cry from the $1.8 million Rubio’s PAC has raised, and the $929,904 Rand Paul’s PAC has taken in.
Cruz’s war chest is likely to grow some following his headline-grabbing filibuster. Jackie Bodnar, spokesperson for the Tea Party activist powerhouse FreedomWorks, said of Cruz’s crusade, “It’s giving me 2010 flashbacks. Republicans especially should know, with all eyes on the Senate, grassroots America is watching them.”
But several Republicans expressed doubt that the activist support Cruz is receiving will ultimately make up for the credibility he’s losing among the big-money crowd.
“When the Wall Street Journal starts to belittle you… that’s what these people read every day,” said one senior GOP aide.
A spokesman for Cruz declined to comment.
Subscribe to:
Posts (Atom)